Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer.

J Tol; M. Koopman; A. Cats; J. Rodenburg; G.J. Creemers; J.G. Schrama; F.L. Erdkamp; A.H. Vos; C.J. van Groeningen; H.A. Sinnige; D.J. Richel; E.E. Voest; J.R. Dijkstra; M.E. Vink Borger; N.F. Antonini; L. Mol; J.H.J.M van Krieken; O. Dalesio; C.J. Punt

Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer.

Translated title of the contribution: Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer.

J Tol
, M. Koopman
, A. Cats
, J. Rodenburg
, G.J. Creemers
, J.G. Schrama
, F.L. Erdkamp
, A.H. Vos
, C.J. van Groeningen
, H.A. Sinnige
, D.J. Richel
, E.E. Voest
, J.R. Dijkstra
, M.E. Vink Borger
, N.F. Antonini
, L. Mol
, J.H.J.M van Krieken
, O. Dalesio
, C.J. Punt

Research output: Contribution to journal › Article › Academic › peer-review

Translated title of the contribution	Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer.
Original language	Undefined/Unknown
Pages (from-to)	563-572
Number of pages	10
Journal	New England Journal of Medicine
Volume	360
Issue number	6
Publication status	Published - 2009

Cite this

Tol, J., Koopman, M., Cats, A., Rodenburg, J., Creemers, G. J., Schrama, J. G., Erdkamp, F. L., Vos, A. H., van Groeningen, C. J., Sinnige, H. A., Richel, D. J., Voest, E. E., Dijkstra, J. R., Vink Borger, M. E., Antonini, N. F., Mol, L., van Krieken, J. H. J. M., Dalesio, O., & Punt, C. J. (2009). Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. New England Journal of Medicine, 360(6), 563-572.

@article{c5ae48870eef4482af2fefe165b89b77,

title = "Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer.",

author = "J Tol and M. Koopman and A. Cats and J. Rodenburg and G.J. Creemers and J.G. Schrama and F.L. Erdkamp and A.H. Vos and \{van Groeningen\}, C.J. and H.A. Sinnige and D.J. Richel and E.E. Voest and J.R. Dijkstra and \{Vink Borger\}, M.E. and N.F. Antonini and L. Mol and \{van Krieken\}, J.H.J.M and O. Dalesio and C.J. Punt",

year = "2009",

language = "Undefined/Unknown",

volume = "360",

pages = "563--572",

journal = "New England Journal of Medicine",

issn = "0028-4793",

publisher = "Massachussetts Medical Society",

number = "6",

}

Tol, J, Koopman, M, Cats, A, Rodenburg, J, Creemers, GJ, Schrama, JG, Erdkamp, FL, Vos, AH, van Groeningen, CJ, Sinnige, HA, Richel, DJ, Voest, EE, Dijkstra, JR, Vink Borger, ME, Antonini, NF, Mol, L, van Krieken, JHJM, Dalesio, O & Punt, CJ 2009, 'Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer.', New England Journal of Medicine, vol. 360, no. 6, pp. 563-572.

TY - JOUR

T1 - Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer.

AU - Tol, J

AU - Koopman, M.

AU - Cats, A.

AU - Rodenburg, J.

AU - Creemers, G.J.

AU - Schrama, J.G.

AU - Erdkamp, F.L.

AU - Vos, A.H.

AU - van Groeningen, C.J.

AU - Sinnige, H.A.

AU - Richel, D.J.

AU - Voest, E.E.

AU - Dijkstra, J.R.

AU - Vink Borger, M.E.

AU - Antonini, N.F.

AU - Mol, L.

AU - van Krieken, J.H.J.M

AU - Dalesio, O.

AU - Punt, C.J.

PY - 2009

Y1 - 2009

M3 - Article

SN - 0028-4793

VL - 360

SP - 563

EP - 572

JO - New England Journal of Medicine

JF - New England Journal of Medicine

IS - 6

ER -